Civica
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: Rising liability awards

Asia is no longer the benign liability environment that it once was. Michael Griffiths, regional director of healthcare at Aon Singapore, explains why.

Imagine you are walking along a footpath in a suburban street somewhere in Asia. Not far ahead of you is a woman on a bicycle, riding on the same footpath. As she rides towards you, a bundle of overhead cables from an adjacent building site falls suddenly on to the street and hits the cyclist, knocking her to the ground.

You rush forward to assist, as do workers from the building site, and everyone is relieved to discover that the cyclist has not been seriously hurt. She is taken to hospital for a check-up, perhaps some treatment for cuts and bruises, but overall it seems that she has had a lucky escape. You would imagine that the owners of the building site will cover the cost of her check-up, repairs to her bicycle, and possibly offer a small apology gift, and that would be the end of the matter.

If this had happened in Australia or the US where people tend to be more litigious, the courts may award higher damages, but here in Asia, people generally do not like to sue, and the courts are generally far more conservative. Well, maybe they used to be, but times have changed.

On 15 October 2009, Ms Siew Pick Chiang, a 42 year-old woman, was cycling along a public path in Singapore, when she was struck by a bundle of overhead cables that had fallen from a building site. Ms Siew suffered only minor physical injuries, but the post-traumatic stress disorder she developed following the accident was so serious that she was hospitalised on at least 18 occasions, and at one stage remained in hospital for over two years. In 2012, she brought legal action against an engineering and construction firm, the main contractor of the building site, seeking damages of S$26 million (US$18.3 million). This amount included over S$13.6 million in medical costs alone, as well as claims for the cost of care givers, loss of income, and S$1.25 million in taxi fares.  

On 1 December last year, the Singapore High Court handed down its judgment. The defendant was found to be fully liable for the injuries suffered by Ms Siew, and was ordered to pay a total of S$8.645 million in damages. This represents the largest ever personal accident award made by the Singapore Courts, nearly S$6 million higher than the previous high water mark.

In our view, this case represents only the latest example of a much wider trend in Asia – that increasing amounts of damages are being awarded by courts.

An award of damages tends to reflect, among other things, the cost of living in the country where it is made. In Asian countries such as Singapore, Japan, Hong Kong, and Korea, the cost of living is now amongst the highest in the world. When it becomes possible for an individual to incur S$13.6 million in medical costs and S$1.25 million in taxi fares, it is inevitable that liability awards in those countries continue to rise.

Insurance brokers can sometimes make for gloomy dinner companions. Part of our job is to highlight to clients the scale of the risks they face, and how and where things could go wrong. Quite understandably, some of my clients respond with scepticism when I tell them that Asia is not the benign liability environment that it once was. They ask to see the proof. In my view, the Singapore High Court has just provided it.

Posted on: 23/02/2017 UTC+08:00


News

First REIT, the SGX healthcare real estate investment trust owned by Indonesia’s Lippo Group, has reported a 0.9% rise in distribution per unit (DPU) of S$0.0214 for the third quarter of the year.
Metlifecare, New Zealand’s second-largest listed retirement village operator, plans to spend NZ$240 million (US$167.2 million) to develop a waterfront retirement village at Scott Point, in the Auckland suburb of Hobsonville.
Thonburi Healthcare Group, the country's third largest hospital operator, has inked an MoU with Korea’s Green Cross MS and Green Cross Laboratories.
At its annual general meeting at the end of last week, Gordon Ballantyne, new chief executive of Healthscope, Australia’s second largest private healthcare operator, said that he expected current private hospital market conditions to continue in the short term.
Hong Kong-listed healthcare company China Wah Yan Healthcare plans to consolidate its shares. The move has been pushed onto the company to comply with trading requirements.
Monash IVF Group, Australia’s second largest fertility treatment provider, has appointed David Morris as the CEO and managing director effective from 13 November. After eight years, James Thiedeman stepped down in May.
SGX-listed Singapore Medical Group, a multi-disciplinary specialist healthcare services provider has announced its latest acquisition.
Malaysia's Top Glove is on the acquisition trail. The world’s largest rubber glove manufacture has signed an MoU to buy all the ordinary shares of Eastern Press for M$47.25 million (US$11.18 million) in cash. Eastern Press is principally engaged as a printer and supplier of packaging material. It is also the major supplier of packaging material to Top Glove's subsidiaries in Malaysia.



Analysis

Is there a case to be made for a merger between Metlifecare and Summerset Group, New Zealand’s second and third-largest listed retirement village operators? First NZ Capital reckons so and analyst Arie Dekker makes an eloquent case for it in a new research note.
Stephenson Harwood’s Tom Platts, Ben Hickson and Su Wai Phyo report on key changes implemented by the Myanmar government to facilitate much-needed foreign investment in the country’s healthcare sector.
In the lead-up to the UN’s International Day of the Older Persons on 1 October, Jason Sadler, president, Cigna International Markets, looks at the impact of an aging population on the world’s healthcare system and the role that digital technology will play in meeting this new challenge.
By 2042 there will be more over-65s in Asia than the populations of the Eurozone and North America combined. We look at the business opportunities this creates.
Albert Wong argues that biomedical technology should not be ignored and explains how the Hong Kong Science and Technology Parks Corporation can support it.
Jacob Pope explains why medical tourism remains one of the region’s most significant industries.
APACMed’s Fredrik Nyberg looks at how local and multinational IVD companies are developing novel solutions for Asia’s unique needs.
It is perhaps a curious line in the sand to draw, but the new hospital in Dunedin, the second-largest city in the South Island of New Zealand, is gearing up to be a significant battle in the use of private-public partnership funding in the APAC region.


Civica

Podcasts

AON

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices